TPMMuckraker

Rep. Ross Blames ‘Left-Wing, Special Interest Conspiracy’ For Pharmacy Sale Story

Rep. Ross Blames ‘Left-Wing, Special Interest Conspiracy’ For Pharmacy Sale Story

The AP has now taken a crack at the story of the sale of Rep. Mike Ross’s family pharmacy, for a possibly inflated price of $420,000, to a big drug store chain.

And it elicited yet another response from Ross, Democrat of Arkansas, on the 2007 sale of the pharmacy. He can’t remember how he and USA Drug settled on the price for the land and the building. From an interview with AP:

He said USA Drug had approached him in early to mid-2007 about buying the pharmacy, but that his memory was hazy on several key details of the sale — including who proposed the $420,000 price tag.

“There was very little negotiation. … I think most family pharmacies will tell you that when a chain comes in to buy you, they usually come with their best offer and there’s not much negotiation that goes on,” Ross said.

Ross also blusters:

The Democratic congressman called the story part of a “left-wing, special interest conspiracy against me.”

As we’ve noted, it’s simply not the case that ProPublica, which reported the story, and Politico, which ran it, are “left-wing” or part of any “special interest.”

Mike Ross, ProPublica, USA Drug

Editor & Publisher

Josh Marshall

Managing Editor

David Kurtz

Senior Associate Editor

Paul Werdel

Associate Editor

Sara Libby

Assistant Editor

Igor Bobic

Reporters

Brian Beutler

Carl Franzen

Sahil Kapur

Eric Kleefeld

Eric Lach

Nick Martin

Evan McMorris-Santoro

Ryan J. Reilly

Benjy Sarlin

Front Page Editor

David Taintor

Poll Editor

Kyle Leighton

News Writer

Pema Levy

Video Editor

Michael Lester

Polling Fellow

Tom Kludt

Video Fellow

Clayton Ashley

Research Interns

Michael Brooks

Publishing Intern

Christopher O’Driscoll

Miles Read

General Manager & General Counsel

Millet Israeli

VP, Ad Sales

Bruce Ellerstein

Waldo Tibbetts

Bob Edmunds

Manager, Ad Operations and Sales Support

Versha Sharma

Deputy Publisher

Callie Schweitzer

Director of Technology

Eric Buth

Designer/Developer

Ni Mu

Matthew Wozniak

Tech Fellow

Dennis Cahillane